PULMONARY REHABILITATION IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS: COMPARISON WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE

被引:0
|
作者
Arizono, Shinichi [1 ,3 ]
Taniguchi, Hiroyuki [2 ]
Sakamoto, Koji [4 ]
Kondoh, Yasuhiro [2 ]
Kimura, Tomoki [2 ]
Kataoka, Kensuke [2 ]
Ogawa, Tomoya [1 ]
Watanabe, Fumiko [1 ]
Tabira, Kazuyuki [5 ]
Kozu, Ryo [6 ]
机构
[1] Tosei Gen Hosp, Dept Rehabil, Seto, Aichi, Japan
[2] Tosei Gen Hosp, Dept Resp Med & Allergy, 160 Nishioiwake Cho, Seto, Aichi 4898642, Japan
[3] Seirei Christopher Univ, Sch Rehabil Sci, Hamamatsu, Shizuoka, Japan
[4] Nagoya Univ, Grad Sch Med, Dept Resp Med, Nagoya, Aichi, Japan
[5] Kio Univ, Grad Sch Hlth Sci, Div Hlth Sci, Koryo, Nara, Japan
[6] Nagasaki Univ, Grad Sch Biomed Sci, Dept Cardiopulm Rehabil Sci, Nagasaki, Nagasaki, Japan
关键词
endurance time; idiopathic pulmonary fibrosis; COPD; pulmonary rehabilitation; exercise capacity; QUALITY-OF-LIFE; EXERCISE CAPACITY; WEAKNESS CONTRIBUTES; QUADRICEPS WEAKNESS; LIMITATION; COPD; DIAGNOSIS; SYMPTOMS; SOCIETY; TRIAL;
D O I
暂无
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: While the efficacy of pulmonary rehabilitation (PR) in chronic obstructive pulmonary disease (COPD) has been well established, emerging evidence also suggests its benefit in idiopathic pulmonary fibrosis (IPF). However, the differences and similarities between how PR affects diseases with different physiologies remain unknown. Objective: This study aimed to compare the efficacy of PR in COPD and IPF patients by performing multifactorial evaluation with various exercise capacity measurements, and dyspnea and health-related quality of life (QoL) assessment. Methods: Twenty-two IPF patients (% vital capacity: 72%) and 27 COPD patients (% forced expiratory volume(1): 43%) were recruited. Subjects who completed a 10-week outpatient PR program were analyzed. We assessed five exercise capacity indicators (6-minute walking distance, incremental shuttle walking distance, endurance time, peak work rate, and peak values for oxygen uptake [ peak VO2]), dyspnea (Baseline Dyspnea Index: BDI), and health-related QoL (St. George's Respiratory Questionnaire: SGRQ) at baseline and immediately following completion of the PR program. Results: After 10 weeks of PR, all exercise capacity measurements, except VO2, as well as BDI and SGRQ score improved significantly (p<0.05) in both disease groups. The magnitude of the observed changes in each outcome, assessed by the effect size, was comparable between IPF and COPD patients. This was also true for endurance time, the measurement most responsive to PR, with a large effect size. Conclusions: PR can result in comparable improvements in exercise capacity, including endurance time, and dyspnea and HRQoL in both IPF and COPD patients after 10 weeks of exercise training.
引用
收藏
页码:283 / 289
页数:7
相关论文
共 50 条
  • [21] Pulmonary rehabilitation in chronic obstructive pulmonary disease
    Saey, D.
    Bernard, S.
    Gagnon, P.
    Laviolette, L.
    Soicher, J.
    Maltais, F.
    Esgagne, P.
    Coats, V.
    Devost, A. -A.
    PANMINERVA MEDICA, 2009, 51 (02) : 95 - 114
  • [22] Alterations in Adenosine Metabolism and Signaling in Patients with Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis
    Zhou, Yang
    Murthy, Jayasimha N.
    Zeng, Dewan
    Belardinelli, Luiz
    Blackburn, Michael R.
    PLOS ONE, 2010, 5 (02):
  • [23] Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease
    Lee, Sung-Soon
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2006, 49 (04): : 342 - 346
  • [24] Pulmonary rehabilitation in chronic obstructive pulmonary disease
    Folgering, H
    Rooyackers, J
    EUROPEAN RESPIRATORY JOURNAL, 1998, 11 (03) : 520 - 523
  • [25] Alterations in Adenosine Metabolism and Signaling in Patients with Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis
    Zhou, Y.
    Murthy, J.
    Blackburn, M. R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [26] THE BURDEN OF COMORBIDITY IN IDIOPATHIC PULMONARY FIBROSIS VERSUS CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    Chapman, R.
    Ozaltin, B.
    Direk, K.
    Jacob, J.
    THORAX, 2023, 78 (SUPPL_4) : A10 - A11
  • [27] Pulmonary hypertension associated with chronic obstructive lung disease and idiopathic pulmonary fibrosis
    Adir, Yochai
    Harari, Sergio
    CURRENT OPINION IN PULMONARY MEDICINE, 2014, 20 (05) : 414 - 420
  • [28] Innate immunity proteins in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis
    Tsoumakidou, Maria
    Bouloukaki, Izolde
    Thimaki, Katerina
    Tzanakis, Nikos
    Siafakas, Nikos M.
    EXPERIMENTAL LUNG RESEARCH, 2010, 36 (06) : 373 - 380
  • [29] Circulating Desmosine Levels In Idiopathic Pulmonary Fibrosis And Chronic Obstructive Pulmonary Disease
    Robberts, B.
    Drent, M.
    Spanbroek, M.
    Van den Ouweland, J. M.
    Zanen, P.
    Van Moorsel, C. H. M.
    Wijnen, P. A.
    Janssens, W.
    Janssen, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [30] Abnormal Lung Aging in Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis
    Faner, Rosa
    Rojas, Mauricio
    MacNee, William
    Agusti, Alvar
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2012, 186 (04) : 306 - 313